GlassScriptPhysician profile
Megha Garg
NPI 1982982617
$2,298.18
in general payments reported to CMS, 2019-2025
17 companies · $158 in 2025
The $158 reported for 2025 was less than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $479 · 2020: $263 · 2021: $525 · 2022: $288 · 2023: $504 · 2024: $80.26 · 2025: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $644 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $644.02 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $511.94 | 2020-2023 | Nucala, Benlysta |
| Abbvie INC. | $322.43 | 2019-2025 | |
| Janssen Scientific Affairs, LLC | $310.93 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $260.78 | 2020-2025 | Saphnelo, Tezspire |
| Janssen Biotech, INC. | $214.63 | 2022-2023 | Tremfya |
| Amgen INC. | $177.39 | 2023-2025 | Tezspire, Tavneos, Enbrel |
| Lilly USA, LLC | $133.25 | 2019-2023 | Taltz, Olumiant |
| Genentech, INC. | $115.00 | 2019 | |
| Ucb, INC. | $73.61 | 2023-2024 | Cimzia |
| Genzyme Corporation | $58.61 | 2019-2025 | |
| Covis Pharma Gmbh | $34.44 | 2021 | |
| Grifols USA, LLC | $25.18 | 2021 | |
| Sobi, INC | $20.30 | 2021 | |
| Genentech USA, INC. | $15.37 | 2019 | |
| Kaleo, INC. | $12.53 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $11.79 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megha Garg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.